{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:33:52Z","timestamp":1793064832941,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"1.Health Research Project of Hunan Provincial Health Commission"},{"name":"2.Health Research Project of Hunan Provincial Health Commission"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41417-026-01086-9","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:34:11Z","timestamp":1790825651000},"page":"1214-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["METTL3-mediated m\u2076A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells"],"prefix":"10.1038","volume":"33","author":[{"given":"Huan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhongCong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuXuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6763-9814","authenticated-orcid":false,"given":"ZhengTai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"1086_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1086_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"1086_CR3","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71:264\u201379.","journal-title":"CA Cancer J Clin"},{"key":"1086_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000334462","volume":"81","author":"J Matsubara","year":"2011","unstructured":"Matsubara J, Shimada Y, Kato K, Nagai Y, Iwasa S, Nakajima TE, et al. Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancer. Oncology. 2011;81:291\u20137.","journal-title":"Oncology"},{"key":"1086_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2741\/4210","volume":"19","author":"J Bornschein","year":"2014","unstructured":"Bornschein J, Leja M, Kupcinskas J, Link A, Weaver J, Rugge M, et al. Molecular diagnostics in gastric cancer. Front Biosci (Landmark Ed). 2014;19:312\u201338.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1086_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1537861","volume":"12","author":"IM Artika","year":"2025","unstructured":"Artika IM, Arianti R, Demeny MA, Kristof E. RNA modifications and their role in gene expression. Front Mol Biosci. 2025;12:1537861.","journal-title":"Front Mol Biosci"},{"key":"1086_CR7","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.62347\/XMAF1290","volume":"15","author":"L Jiang","year":"2025","unstructured":"Jiang L, Chen Y, Luo Q, Song G. Role and mechanisms of m6A demethylases in digestive system tumors. Am J Cancer Res. 2025;15:1436\u201360.","journal-title":"Am J Cancer Res"},{"key":"1086_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1565738","volume":"16","author":"Z Xu","year":"2025","unstructured":"Xu Z, Sun B, Wang W, Fan Y, Su J, Sun J, et al. Research progress on m6A and drug resistance in gastrointestinal tumors. Front Pharm. 2025;16:1565738.","journal-title":"Front Pharm"},{"key":"1086_CR9","doi-asserted-by":"crossref","unstructured":"Yan W, Saqirile, Li K, Li K, Wang C. The role of N6-methyladenosine in mitochondrial dysfunction and pathology. Int J Mol Sci. 2025;26:3624.","DOI":"10.3390\/ijms26083624"},{"key":"1086_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40164-025-00648-1","volume":"14","author":"YP Ding","year":"2025","unstructured":"Ding YP, Liu CC, Yu KD. RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond. Exp Hematol Oncol. 2025;14:48.","journal-title":"Exp Hematol Oncol"},{"key":"1086_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.625257","volume":"11","author":"S Li","year":"2021","unstructured":"Li S, Yang X, Li W, Chen Z. Comprehensive analysis of E2F family members in human gastric cancer. Front Oncol. 2021;11:625257.","journal-title":"Front Oncol"},{"key":"1086_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.omtm.2020.07.017","volume":"18","author":"X Liu","year":"2020","unstructured":"Liu X, Hu C. Novel potential therapeutic target for E2F1 and prognostic factors of E2F1\/2\/3\/5\/7\/8 in human gastric cancer. Mol Ther Methods Clin Dev. 2020;18:824\u201338.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1086_CR13","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.2147\/CMAR.S172332","volume":"10","author":"ZL Liu","year":"2018","unstructured":"Liu ZL, Bi XW, Liu PP, Lei DX, Wang Y, Li ZM, et al. Expressions and prognostic values of the E2F transcription factors in human breast carcinoma. Cancer Manag Res. 2018;10:3521\u201332.","journal-title":"Cancer Manag Res"},{"key":"1086_CR14","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.21037\/tcr-22-218","volume":"11","author":"Z Tan","year":"2022","unstructured":"Tan Z, Chen M, Peng F, Yang P, Peng Z, Zhang Z, et al. E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma. Transl Cancer Res. 2022;11:2713\u201332.","journal-title":"Transl Cancer Res"},{"key":"1086_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria and Cancer. Cell. 2016;166:555\u201366.","journal-title":"Cell"},{"key":"1086_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell. 2008;13:472\u201382.","journal-title":"Cancer Cell"},{"key":"1086_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2025.103017","volume":"127","author":"K Ahuja","year":"2025","unstructured":"Ahuja K, Motiani RK. Calcium acts as a critical determinant of mitochondria-nuclear networking driven retrograde signaling. Cell Calcium. 2025;127:103017.","journal-title":"Cell Calcium"},{"key":"1086_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12551-025-01270-5","volume":"17","author":"ZV Bochkova","year":"2025","unstructured":"Bochkova ZV, Baizhumanov AA, Yusipovich AI, Morozova KI, Nikelshparg EI, Fedotova AA, et al. The flexible chain: regulation of structure and activity of ETC complexes defines rate of ATP synthesis and sites of superoxide generation. Biophys Rev. 2025;17:55\u201388.","journal-title":"Biophys Rev"},{"key":"1086_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113840","volume":"383","author":"X Li","year":"2025","unstructured":"Li X, Zhang H, Cao Z, Xiao H, Weng C, Zheng Q. Mitochondria-targeted and ROS-sensitive main-chain ruthenium polymer overcomes cancer drug resistance. J Control Release. 2025;383:113840.","journal-title":"J Control Release"},{"key":"1086_CR20","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1007\/s11033-023-08421-5","volume":"50","author":"WL Tan","year":"2023","unstructured":"Tan WL, Subha ST, Mohtarrudin N, Cheah YK. An insight into the associations between microRNA expression and mitochondrial functions in cancer cell and cancer stem cell. Mol Biol Rep. 2023;50:5395\u2013405.","journal-title":"Mol Biol Rep"},{"key":"1086_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410880","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Wang H, Liang Y, Liu M, Huang Q, Wang M, et al. E2F2 reprograms macrophage function by modulating material and energy metabolism in the progression of metabolic dysfunction-associated steatohepatitis. Adv Sci. 2024;11:e2410880.","journal-title":"Adv Sci"},{"key":"1086_CR22","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69:1193\u2013205.","journal-title":"Gut"},{"key":"1086_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1065-4","volume":"18","author":"B Yue","year":"2019","unstructured":"Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18:142.","journal-title":"Mol Cancer"},{"key":"1086_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102628","volume":"60","author":"J Son","year":"2023","unstructured":"Son J, Jung O, Kim JH, Park KS, Kweon HS, Nguyen NT, et al. MARS2 drives metabolic switch of non-small-cell lung cancer cells via interaction with MCU. Redox Biol. 2023;60:102628.","journal-title":"Redox Biol"},{"key":"1086_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41392-020-0155-5","volume":"5","author":"Y Liu","year":"2020","unstructured":"Liu Y, Jin M, Wang Y, Zhu J, Tan R, Zhao J, et al. MCU-induced mitochondrial calcium uptake promotes mitochondrial biogenesis and colorectal cancer growth. Signal Transduct Target Ther. 2020;5:59.","journal-title":"Signal Transduct Target Ther"},{"key":"1086_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-02129-1","volume":"15","author":"X Fan","year":"2025","unstructured":"Fan X, Qiao W, Guo X, Wang J, Zhao L. METTL14-mediated miR-122-5p maturation stimulated tumor progression by targeting KAT2A in hepatocellular carcinoma. Sci Rep. 2025;15:17884.","journal-title":"Sci Rep"},{"key":"1086_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq3052","volume":"11","author":"H Huang","year":"2025","unstructured":"Huang H, Li X, Luo J, Gao C, Yang M, Xu J, et al. FTO regulates ELK3-mediated metabolic rewiring and represents a unique therapeutic target in T cell leukemia. Sci Adv. 2025;11:eadq3052.","journal-title":"Sci Adv"},{"key":"1086_CR28","doi-asserted-by":"crossref","unstructured":"Xiao S, Duan S, Caligiuri MA, Ma S, Yu J. YTHDF2: a key RNA reader and antitumor target. Trends Immunol. 2025;46:485\u201398.","DOI":"10.1016\/j.it.2025.04.003"},{"key":"1086_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10120-025-01620-y","volume":"28","author":"P Mesquita","year":"2025","unstructured":"Mesquita P, Coelho A, Ribeiro AS, P\u00f3voas LFC, de Oliveira C, Le\u00e7a N, et al. The RNA-binding protein YTHDF3 affects gastric cancer cell migration and response to paclitaxel by regulating EZRIN. Gastric Cancer. 2025;28:760\u201375.","journal-title":"Gastric Cancer"},{"key":"1086_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103647","volume":"83","author":"C Xu","year":"2025","unstructured":"Xu C, Shen T, Feng L, Wang L, Li S, Ding R, et al. FTO facilitates colorectal cancer chemoresistance via regulation of NUPR1-dependent iron homeostasis. Redox Biol. 2025;83:103647.","journal-title":"Redox Biol"},{"key":"1086_CR31","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.7150\/ijbs.45231","volume":"16","author":"ZM Zhu","year":"2020","unstructured":"Zhu ZM, Huo FC, Pei DS. Function and evolution of RNA N6-methyladenosine modification. Int J Biol Sci. 2020;16:1929\u201340.","journal-title":"Int J Biol Sci"},{"key":"1086_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111745","volume":"131","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang L, Chen J, Shao W. Decoding intricate interactions between m6A modification with mRNAs and non-coding RNAs in cervical cancer: molecular mechanisms and clinical implications. Cell Signal. 2025;131:111745.","journal-title":"Cell Signal"},{"key":"1086_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189317","volume":"1880","author":"X Qiu","year":"2025","unstructured":"Qiu X, Gao Q, Wang J, Zhang Z, Tao L. The microbiota-m(6)A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers. Biochim Biophys Acta Rev Cancer. 2025;1880:189317.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1086_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142880","volume":"309","author":"ZM Zhu","year":"2025","unstructured":"Zhu ZM, Huo FC, Shi C, Li MT, Zhou Y, Zhang LS, et al. METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14. Int J Biol Macromol. 2025;309:142880.","journal-title":"Int J Biol Macromol"},{"key":"1086_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149468","volume":"955","author":"Y Shi","year":"2025","unstructured":"Shi Y, Liu J, Cheng Q, Wu S, Song W, Wang K, et al. METTL3\/IGF2BP3 mediates ORC6 via N6-methyladenosine modification to promote the progression of pancreatic ductal adenocarcinoma. Gene. 2025;955:149468.","journal-title":"Gene"},{"key":"1086_CR36","doi-asserted-by":"crossref","unstructured":"Gan L, Kong Y, Shi H, Zhang C, Tian C, Chen H. METTL3 promotes cutaneous T-cell lymphoma progression by regulating ARHGEF12 expression. Int J Mol Sci. 2025;26:3640.","DOI":"10.3390\/ijms26083640"},{"key":"1086_CR37","doi-asserted-by":"crossref","unstructured":"Fang M, Li Y, Wang P, Wang Y, Wang X, Wa X, et al. METTL3 inhibition restores PD-L1 expression and CD8+ T-cell cytotoxic function in immunotherapy treated gastric cancer. Cancer Immunol Res. 2025;133:1037\u201352.","DOI":"10.1158\/2326-6066.CIR-24-1179"},{"key":"1086_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1483435","volume":"14","author":"Z Yu","year":"2024","unstructured":"Yu Z, Yang Y. METTL3 as a potential therapeutic target in gastric cancer. Front Oncol. 2024;14:1483435.","journal-title":"Front Oncol"},{"key":"1086_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70162","volume":"39","author":"Y He","year":"2025","unstructured":"He Y, Ge J, Zhao S, Zhou F, Zou W, Gao Y, et al. METTL3-mediated NFAT5 upregulation promotes cervical cancer progression through enhancing the mitochondrial function by transcriptional regulation of PRDX1. J Biochem Mol Toxicol. 2025;39:e70162.","journal-title":"J Biochem Mol Toxicol"},{"key":"1086_CR40","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1038\/s41388-021-01753-1","volume":"40","author":"FC Huo","year":"2021","unstructured":"Huo FC, Zhu ZM, Zhu WT, Du QY, Liang J, Mou J. METTL3-mediated m(6)A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2. Oncogene. 2021;40:2968\u201381.","journal-title":"Oncogene"},{"key":"1086_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70428","volume":"29","author":"H Xiao","year":"2025","unstructured":"Xiao H, Fei M, Xu Q, Gao Y, Feng R, Liang C, et al. MATN1-AS1 Promotes Tumour Metastasis and Sunitinib Resistance via E2F2 in Clear Cell Renal Cell Carcinoma. J Cell Mol Med. 2025;29:e70428.","journal-title":"J Cell Mol Med"},{"key":"1086_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104353","volume":"86","author":"TT Liu","year":"2022","unstructured":"Liu TT, Yang H, Zhuo FF, Yang Z, Zhao MM, Guo Q, et al. Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy. EBioMedicine. 2022;86:104353.","journal-title":"EBioMedicine"},{"key":"1086_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1397303","volume":"15","author":"Y Gao","year":"2024","unstructured":"Gao Y, Qiao X, Liu Z, Zhang W. The role of E2F2 in cancer progression and its value as a therapeutic target. Front Immunol. 2024;15:1397303.","journal-title":"Front Immunol"},{"key":"1086_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.7150\/jca.61415","volume":"13","author":"Y Shang","year":"2022","unstructured":"Shang Y, Zhang Y, Liu J, Chen L, Yang X, Zhu Z, et al. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer. J Cancer. 2022;13:653\u201368.","journal-title":"J Cancer"},{"key":"1086_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74877-1","volume":"10","author":"JP Rennhack","year":"2020","unstructured":"Rennhack JP, Andrechek ER. Low E2F2 activity is associated with high genomic instability and PARPi resistance. Sci Rep. 2020;10:17948.","journal-title":"Sci Rep"},{"key":"1086_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/15384101.2022.2119515","volume":"22","author":"Z Li","year":"2023","unstructured":"Li Z, Lang Z, Wang T, Qu G, Sui W, Liu J. LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p\/e2f2 axis. Cell Cycle. 2023;22:347\u201360.","journal-title":"Cell Cycle"},{"key":"1086_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2025.05.001","volume":"236","author":"C Li","year":"2025","unstructured":"Li C, Sun J, Ling H, Qin Z, Zhu X, Fu X, et al. MCU regulating bone remodeling and osteogenic function through mitochondrial calcium homeostasis and oxidative stress alteration. Free Radic Biol Med. 2025;236:87\u201397.","journal-title":"Free Radic Biol Med"},{"key":"1086_CR48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12:685\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1086_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2024.102966","volume":"124","author":"I Stejerean-Todoran","year":"2024","unstructured":"Stejerean-Todoran I, Gibhardt CS, Bogeski I. Calcium signals as regulators of ferroptosis in cancer. Cell Calcium. 2024;124:102966.","journal-title":"Cell Calcium"},{"key":"1086_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11033-025-10336-2","volume":"52","author":"PS Chagas","year":"2025","unstructured":"Chagas PS, Garcia CB, Chagas HIS, Yeudall WA, Yu JC, Baban B, et al. Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca(2+) dynamics. Mol Biol Rep. 2025;52:220.","journal-title":"Mol Biol Rep"},{"key":"1086_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.32604\/or.2024.052743","volume":"33","author":"EC So","year":"2025","unstructured":"So EC, Chow LWC, Chuang CM, Chen CY, Wu CH, Shiao LR, et al. MCU-i4, a mitochondrial Ca(2+) uniporter modulator, induces breast cancer BT474 cell death by enhancing glycolysis, ATP production and reactive oxygen species (ROS) burst. Oncol Res. 2025;33:397\u2013406.","journal-title":"Oncol Res"},{"key":"1086_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01740-y","volume":"20","author":"Z Gu","year":"2022","unstructured":"Gu Z, Yu C. Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism. J Nanobiotechnol. 2022;20:528.","journal-title":"J Nanobiotechnol"},{"key":"1086_CR53","doi-asserted-by":"crossref","unstructured":"Grubelnik V, Zmazek J, Marhl M. The synergistic impact of glycolysis, mitochondrial OxPhos, and PEP cycling on ATP production in beta cells. Int J Mol Sci. 2025;26:1454.","DOI":"10.3390\/ijms26041454"},{"key":"1086_CR54","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.bbabio.2010.02.005","volume":"1797","author":"FN Gellerich","year":"2010","unstructured":"Gellerich FN, Gizatullina Z, Trumbeckaite S, Nguyen HP, Pallas T, Arandarcikaite O, et al. The regulation of OXPHOS by extramitochondrial calcium. Biochim Biophys Acta. 2010;1797:1018\u201327.","journal-title":"Biochim Biophys Acta"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01086-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:05:00Z","timestamp":1793063100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01086-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01086-9","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The present study was approved by the Ethics Committee of The First Hospital of Hunan University of Chinese Medicine, and written informed consent was provided by all patients prior to the study start. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and the Declaration of Helsinki, and its later amendments or comparable ethical standards. All animal experiments complied with the ARRIVE guidelines and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of The First Hospital of Hunan University of Chinese Medicine.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}